The Fort Worth Press - Once-taboo ketamine booms for US at-home mental care

USD -
AED 3.672504
AFN 65.000368
ALL 81.216919
AMD 362.051328
ANG 1.789785
AOA 917.000367
ARS 1515.25437
AUD 1.435956
AWG 1.80125
AZN 1.70397
BAM 1.739803
BBD 2.01708
BDT 123.195303
BGN 1.747831
BHD 0.378775
BIF 2997.464751
BMD 1
BND 1.281146
BOB 11.69239
BRL 5.065104
BSD 1.001468
BTN 95.050483
BWP 13.720589
BYN 3.015879
BYR 19600
BZD 2.014233
CAD 1.41575
CDF 2313.50392
CHF 0.825932
CLF 0.024881
CLP 979.255437
CNY 6.691204
CNH 6.686704
COP 3173.953654
CRC 455.099408
CUC 1
CUP 24.035938
CVE 98.087444
CZK 21.645304
DJF 178.33919
DKK 6.651204
DOP 61.433083
DZD 133.824668
EGP 53.529689
ERN 15
ETB 163.585998
EUR 0.889904
FJD 2.26765
FKP 0.750199
GBP 0.752078
GEL 2.590391
GGP 0.750199
GHS 11.695058
GIP 0.750199
GMD 73.503851
GNF 8810.21216
GTQ 7.652004
GYD 209.527198
HKD 7.84815
HNL 26.885202
HRK 6.703804
HTG 131.147978
HUF 323.310388
IDR 18053
ILS 3.09465
IMP 0.750199
INR 94.965504
IQD 1518.213762
IRR 1795877.503816
ISK 121.180386
JEP 0.750199
JMD 159.195837
JOD 0.70904
JPY 158.01504
KES 130.098296
KGS 87.450384
KHR 4070.631144
KMF 440.00035
KPW 899.999961
KRW 1334.740383
KWD 0.31082
KYD 0.834586
KZT 453.195748
LAK 22534.359294
LBP 89683.40524
LKR 331.690611
LRD 170.751234
LSL 16.462394
LTL 2.95274
LVL 0.60489
LYD 6.431526
MAD 9.729662
MDL 17.966464
MGA 4507.405595
MKD 54.836988
MMK 2099.858992
MNT 3597.263832
MOP 8.096339
MRU 40.037362
MUR 47.230378
MVR 15.460378
MWK 1736.600987
MXN 18.492904
MYR 4.083204
MZN 63.903729
NAD 16.462394
NGN 1331.210377
NIO 36.854512
NOK 9.427704
NPR 152.081128
NZD 1.767253
OMR 0.382413
PAB 1.001468
PEN 3.444825
PGK 4.547436
PHP 62.986038
PKR 277.237468
PLN 3.88825
PYG 5719.877241
QAR 3.660721
RON 4.730604
RSD 104.461148
RUB 84.13468
RWF 1478.183516
SAR 3.752837
SBD 8.064647
SCR 13.905529
SDG 601.503676
SEK 9.912404
SGD 1.282104
SHP 0.754745
SLE 24.680371
SLL 20969.504398
SOS 572.343548
SRD 37.794504
STD 20697.981008
STN 21.794245
SVC 8.763065
SYP 13001.999685
SZL 16.455989
THB 33.445038
TJS 9.228751
TMT 3.51
TND 2.98768
TOP 2.40776
TRY 49.513804
TTD 6.798915
TWD 32.453604
TZS 2646.44398
UAH 44.920874
UGX 4136.458658
UYU 40.314905
UZS 12073.121914
VES 878.910604
VND 25894.5
VUV 119.757204
WST 2.787783
XAF 583.738825
XAG 0.017551
XAU 0.000240063761
XCD 2.70255
XCG 1.804919
XDR 0.707052
XOF 583.738825
XPF 106.089045
YER 236.150363
ZAR 16.494037
ZMK 9001.203584
ZMW 20.049815
ZWL 321.999592
SSP 5758.113256
MXV 2.088032
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

S.Weaver--TFWP